Penumbra INC Form 4 insider transactions

Boston Scientific Corporation announced a definitive agreement to acquire Penumbra, Inc. for approximately $14.5 billion in a cash and stock transaction, expanding its cardiovascular and neurovascular portfolios.

Penumbra Inc. Director Harpreet Grewal sold 186 shares of common stock for $312.64 per share, executed under a pre-arranged 10b5-1 trading plan.

Penumbra Inc. Director Thomas Wilder sold 186 shares of common stock for $310.72 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Penumbra Inc.'s Chief Financial Officer, Maggie Yuen, reported a disposition of 565 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Penumbra's Chief Accounting Officer, Lambert Shiu, reported the disposition of 300 common stock shares to cover tax withholdings related to restricted stock unit vesting.

Penumbra's EVP, General Counsel, and Secretary, Johanna Roberts, disposed of 1,130 shares of common stock to cover tax withholding obligations.

Penumbra Inc. Director Arani Bose sold 15,000 shares of common stock for over $4.6 million through a pre-arranged Rule 10b5-1 trading plan.

Penumbra's EVP, General Counsel & Secretary, Johanna Roberts, sold 300 shares of common stock for a weighted average price of $300.13 per share pursuant to a pre-arranged trading plan.

Penumbra Inc.'s EVP, General Counsel, and Secretary, Johanna Roberts, sold 600 shares of common stock for approximately $177,000 through a pre-arranged trading plan.

Penumbra Inc. Director Harpreet Grewal sold 100 shares of common stock for $292.98 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Penumbra's EVP, General Counsel, and Secretary, Johanna Roberts, sold 1,800 shares of common stock for $300.06 per share under a pre-arranged trading plan.

Penumbra Inc. Director Arani Bose reported the sale of 7,500 shares and a gift of 1,799 shares of common stock.

Penumbra Inc. Director Arani Bose sold a total of 7,500 shares of common stock for approximately $2.18 million through a pre-arranged 10b5-1 trading plan.

Penumbra's Chief Financial Officer, Maggie Yuen, reported the grant of 3,580 Restricted Stock Units and the disposition of shares for tax obligations.

Penumbra Inc. President Shruthi Narayan reported a planned disposition of 358 common shares in November 2025 to cover tax obligations related to restricted stock unit vesting.

Penumbra's Chief Accounting Officer, Lambert Shiu, reported tax-related stock dispositions and a new RSU grant.

Penumbra's EVP, General Counsel, and Secretary, Johanna Roberts, reported the grant of 3,580 restricted stock units and the withholding of shares for tax obligations.

Penumbra's EVP, General Counsel & Secretary, Johanna Roberts, sold 600 shares of common stock on November 10, 2025, through a pre-arranged 10b5-1 trading plan.

Penumbra Inc. Director Harpreet Grewal sold 186 shares of common stock for $227.58 per share as part of a pre-arranged trading plan.

Penumbra Inc. President Shruthi Narayan sold 1,294 shares of common stock at $252.61 per share to satisfy tax withholding obligations from restricted stock unit vesting.

Penumbra Inc. Director Harpreet Grewal sold 186 shares of common stock for $248.61 per share, reducing beneficial ownership to 8,702 shares.

Johanna Roberts, Penumbra Inc.'s EVP, General Counsel & Secretary, sold 600 shares of common stock on October 1, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Penumbra Inc. Director Thomas Wilder sold 186 shares of common stock for $253.93 per share, executed under a pre-arranged 10b5-1 trading plan.

Penumbra Inc. President Shruthi Narayan was granted 9,170 restricted stock units under the company's equity incentive plan.

Penumbra Inc. Director Harpreet Grewal sold 186 shares of common stock for $272.19 per share, executed under a pre-arranged 10b5-1 trading plan.

Penumbra Inc. CEO Adam Elsesser exercised stock options and subsequently sold a portion of the acquired common stock to cover exercise costs and tax obligations, as detailed in a recent SEC Form 4 filing.

Penumbra's EVP, General Counsel, and Secretary, Johanna Roberts, sold 600 shares of common stock on September 2, 2025, through a pre-arranged 10b5-1 trading plan.

Penumbra Inc. CEO and President Adam Elsesser exercised stock options and sold common stock on August 20, 2025, under a pre-arranged 10b5-1 trading plan.

Penumbra Inc.'s Chief Financial Officer, Maggie Yuen, reported the sale of 2,000 common shares and the exercise of stock options, acquiring 724 shares.

Penumbra Inc. Director Arani Bose sold 12,000 shares of common stock for approximately $3 million through a pre-arranged trading plan.